A Harvard Medical School doctor answers your question about
whether Fosamax, part of a class of drugs used to treat
osteoporosis and cancer patients, can inhibit bone formation.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.